Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Humanized CD19 CAR-T Cells by Shanghai Unicar-Therapy Bio-Medicine Technology for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia): Likelihood of Approval
Humanized CD19 CAR-T Cells is under clinical development by Shanghai Unicar-Therapy Bio-Medicine Technology and currently in Phase II for Acute...